Science Explorer Interactive view Map
Company · Mississauga · Canada

Roche (Canada)

World rank, all time
#26,225
of 42,892
Rank in Canada
#560
of 896
Research works
156
▲ 164% vs 2013–17
Citations
2.4k
15.1 per fractional work
Top-10% rate
17.7%
record average 16.5%
Open access
46%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.04× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.66× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 3.16× its world share, 2 worksImmunology and Micro…Neuroscience: 1.32× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.59× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.18× its world share, 0 worksChemistryComputer Science: 0.50× its world share, 2 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMathematics: 1.68× its world share, 1 worksMathematicsPhysics and Astronomy: 0.76× its world share, 1 worksPhysics and AstronomyHealth Professions: 0.40× its world share, 1 worksHealth ProfessionsMedicine: 2.95× its world share, 33 worksMedicineArts and Humanities: 0.04× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.06× its world share, 0 worksBusiness, Management…Decision Sciences: 1.90× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 4.53× its world share, 6 worksEconomics, Econometr…Psychology: 0.07× its world share, 0 worksPsychologySocial Sciences: 0.17× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Economics, Econometrics and Finance, 4.5×. Every wedge is a field page.

Which keywords describe research at Roche (Canada)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Lymphoma, Rituximab, Immunotherapy, Targeted Therapy, PET Imaging, Chemotherapy, Cost-effectiveness Analysis and Health Utility Measures.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Lymphoma5▲ 48×2 topics
  2. Inflammation4▲ 2.9×17 topics
  3. Rituximab4▲ 41×4 topics
  4. Immunotherapy4▲ 8.2×10 topics
  5. Quality of Life4▲ 4.1×3 topics
  6. Targeted Therapy3▲ 26×4 topics
  7. Chemotherapy3▲ 7.8×9 topics
  8. Epidemiology3▲ 1.38×17 topics
  9. PET Imaging3▲ 32×3 topics
  10. Cost-effectiveness Analysis3▲ 58×1 topic
  11. Health Utility Measures3▲ 58×1 topic
  12. Prognostic Factors3▲ 11×8 topics
  13. Classification3▲ 10×2 topics
  14. Gene Expression Profiling3▲ 58×2 topics
  15. Molecular Profiling3▲ 48×2 topics
  16. Genetic Pathogenesis3▲ 85×1 topic
  17. Hodgkin's Lymphoma3▲ 85×1 topic
  18. Precision Medicine3▲ 9.6×6 topics
  19. Clinical Trials2▲ 6.0×5 topics
  20. Autoantibodies2▲ 16×4 topics
  21. Breast Cancer2▲ 14×5 topics
  22. Biomarkers2▲ 4.8×6 topics
  23. CAR T Cells2▲ 43×1 topic
  24. Cancer Immunotherapy2▲ 21×2 topics
  25. Chimeric Antigen Receptor2▲ 43×1 topic
  26. Tumor Regression2▲ 30×2 topics
  27. Tumor Microenvironment2▲ 6.8×5 topics
  28. Antiphospholipid Syndrome2▲ 60×1 topic
  29. Systemic Lupus Erythematosus2▲ 54×1 topic
  30. ALK Inhibitors2▲ 40×1 topic
  31. EGFR Mutations2▲ 40×1 topic
  32. Radiotherapy2▲ 6.7×4 topics
  33. Dosimetry1▲ 34×2 topics
  34. Glycosylation1▲ 21×2 topics
  35. Immune Checkpoint Blockade1▲ 21×1 topic
  36. PD-1 and PD-L11▲ 21×1 topic
  37. Predictive Modeling1▲ 8.6×2 topics
  38. Quality Assurance1▲ 14×3 topics
  39. Metastatic Breast Cancer1▲ 38×2 topics
  40. Neurodegeneration1▲ 7.6×4 topics

Which research topics does Roche (Canada) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research and Systemic Lupus Erythematosus Research.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 3 works
  2. 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
  3. 3 CAR-T cell therapy research Oncology 2 works
  4. 4 Systemic Lupus Erythematosus Research Rheumatology 2 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 Advanced Radiotherapy Techniques Radiation 1 works
  8. 8 Complex Systems and Decision Making Management Science and Operations Research 1 works
  9. 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  10. 10 Pharmaceutical Economics and Policy Economics and Econometrics 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.9%not open54.1%

World: 28% of research is openly available.

with international co-authors56.5%domestic only43.5%

World: 19% is written across borders.

How has Roche (Canada)'s research output changed?

Output in 2018–2022 was 164% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mississauga

All research institutions in Mississauga

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.